6.5. Analysis.
Comparison 6 High‐dose intravenous omalizumab + steroid versus placebo + steroid (stable steroid), Outcome 5 Number of participants with > 50% reduction in symptom score.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.